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The RNA-binding activity of the interferon-inducible, RNA-dependent protein kinase PKR, expressed from the human PKR 
cDNA, was quantitated using a gel mobility-shift assay. The N-terminal R-domain truncation Wt(1-243] and the full-length 
catalytic mutant K296R(1-551) were analyzed for their abilities to bind adenovirus VAj RNA, human immunodeficiency virus 
TAR RNA, and the synthetic homopolymer pl:pC RNA. The N-terminal 243 amino acid residue form of PKR [Wt(1-243)] 
bound VA~ RNA with similar affinity as the 551 amino acid residue full-lengt h catalytic mutant [K296R(1-551)]. The dissocia- 
tion constant for VAj RNA was approximately 2 X 10 _9 M for both the K296R(1-551) and Wt(1-243) proteins. The K64E 
mutation significantly impaired the VA~ RNA-binding activity as measured with the full4ength double-point mutant PKR 
protein, K64E/K296R(1-551). Using a gel-shift competition assay, the dissociation constants of K296R(1-551) and Wt(1- 
243) for VA~(1-160) RNA and pl:pC RNA were comparable. By contrast, the dissociation constants of K296R(1-551) and 
Wt(1-243) for TAR(1-82) RNA were both about 1 X 10 _7 M. These results suggest that the RNA-binding affinity of PKR is 
approximately 100-fold lower for TAR RNA than for either VA~ RNA or phpC RNA and that the full-length and N-terminal R- 
domain forms of PKR bind RNA with similar affinity. © 1995 Academic Press, Inc. 
INTRODUCTION 
The IFN-induced RNA-dependent protein kinase 
(PKR) 3 is dependent upon RNA for activation of kinase 
activity, a process which involves the autophosphoryla- 
t/on of PKR (Samuel, 1993). Following activation, PKR 
catalyzes the phosphorylation of protein synthesis initia- 
tion factor elF-2 at serine 51 of the ~ subunit (Samuel, 
1979, 1993; Galabru and Hovanessian, 1987; Hershey, 
1989; Pathak eta/., 1988). The PKR-catalyzed phosphory- 
lation of elF-2c~ leads to an inhibition of protein synthesis, 
characterized by the selective inhibition of translation of 
certain mRNAs in transfected cells (Kaufman et al., 1989; 
Samuel and Brody, 1990). 
PKR plays a central role in regulating protein synthesis 
in virus-infected cells (Katze, 1992; Samuel, 1991). Sev- 
eral viruses encode RNAs that are bound by PKR and 
either activate or antagonize the autophosphorylation of
PKR (Katze, 1992; McCormack et al., 1992; Mathews, 
1993; Samuel, 1992). Among the viral RNAs that affect 
PKR catalytic activity are adenovirus VA~ RNA, Epstein- 
Barr virus EBER RNA, reovirus sl mRNA, and human 
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immunodeficiency virus (HIV) TAR RNA (Schneider eta/., 
1985; Galabru eta/., 1989; Clarke eta/., 1991; Bischoff 
and Samuel, 1989; Edery et a/., 1989; SenGupta eta/., 
1990). A common feature of these viral RNAs is their 
ability to form extensive secondary structure. 
The adenovirus VA~ RNA is one of the most highly 
characterized effectors of PKR activity; the VA~ RNA facili- 
tates adenovirus late protein synthesis and antagonizes 
the ant/viral actions of IFN through the inhibition of PKR 
activation (Mathews and Shenk, 1991; Samuel, 1991; Ma- 
thews 1993). At late times after adenovirus infection, dou- 
ble-stranded RNAs capable of activating PKR are formed 
by RNA polymerase II-catalyzed synthesis of the oppos- 
ing transcripts of the viral genome (Maran and Mathews, 
1988). However, viral protein synthesis is maintained by 
the RNA polymerase Ill-catalyzed production of large 
amounts of VA~ RNA (Kitajewski et aL, 1986). VA~ RNA 
binds to PKR, preventing activation and thus the subse- 
quent phosphorylation of elF-2~ (Katze eta/., 1987). An 
adenovirus deletion mutant that does not synthesize the 
VA~ RNA is unable to efficiently replicate when compared 
to wild-type virus (Kitajewski eta/., 1986). However, the 
replication of VA~-deficient adenovirus is rescued in host 
cells which express the S51A mutant elF-2~ that cannot 
be phosphorylated at serine-51 (Davies eta/., 1989; Pa- 
thak et aL, 1988). The structure-function relationship of 
VA~ RNA and its ability to inhibit PKR kinase activation 
has been examined in vitro and in vivo (Mathews, 1993). 
Both the apical stem of VAI RNA and the central core 
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have been implicated in the VArmediated inhibition of 
PKR activation (Furtado et aL, 1989; Ghadge et aL, 1991; 
Pe'ery et al., 1993; Ma and Mathews, 1993). 
Mutational analyses of PKR cDNA clones have local- 
ized the RNA-binding activity to the N-terminal region of 
the kinase (McOormack etaL, 1992; Patel and Sen, 1992; 
Feng etaL, 1992; Katze etaL, 1991). Adenovirus VA~ RNA, 
HIV TAR RNA, and reovirus sl RNA, three natural RNAs 
which affect PKR-enzymic activity (Samuel, 1991), are all 
bound by TrpE-PKR fusion proteins which include the 
N-terminal 98 residues of PKR. By contrast, none of the 
viral RNAs are bound by TrpE-PKR fusion proteins that 
lack the N-terminal region of PKR (McOormack et aL, 
1992). The region of PKR which displays RNA-binding 
activity includes a 20 amino acid core motif, designated 
R~, which is conserved and often repeated in RNA-binding 
proteins from both prokaryotic and eukaryotic cells and 
their viruses (McCormack et al., 1992; St. Johnston et 
aL, 1992). Substitution of R motif consensus residues 
abolishes RNA-binding activity (Chang and Jacobs, 1993; 
McOormack et al., 1994). 
As an extension of our studies on the structure and 
function of the PKR kinase, we have analyzed PKR mu- 
tants for their RNA-binding activity using a gel mobility- 
shift assay. The results of gel mobility-shift analyses con- 
firm and extend in a quantitative manner results obtained 
using a Northwestern gel-blot assay. The N-terminal 243 
amino acid residues are sufficient to mediate RNA-bind- 
ing activity comparable to the full-length 551 residue PKR 
protein; the K64E mutation significantly impairs RNA- 
binding activity. The dissociation constants of K296R(1- 
551) and Wt(1-243) are comparable for both natural and 
synthetic RNAs; however, adenovirus VA~ and synthetic 
pl=pC are bound about 100-fold more efficiently than is 
HIV TAR RNA. 
MATERIALS AND METHODS 
Preparation of PKR for gel mobility-shift analysis 
Recombinant PKR protein for RNA gel mobility-shift 
analysis was prepared from transfected COS cells. 
The construction of the pJC119 expression vectors used 
herein for the production of the PKR proteins was de- 
scribed previously, Wt(1-551) and K296R(1-551) 
(Thomis and Samuel, 1992); Wt(1-243), K64E(1-551), 
and K64E/K296R(1-551) (McOormack et al., 1994). COS 
cells grown as monolayer culture (150-mm dishes, 
Nuclon) with DMEM + 5% FBS were transfected by the 
DEAE-dextran/chloroquine phosphate method using 40 
#g of DNA per 4 ml of serum-free DMEM (Luthman and 
Magnusson, 1983; Munemitsu and Samuel, 1988). Three 
culture dishes were routinely transfected with each 
pSV(PKR) construction; harvest was at 48 hr post-trans- 
fection. Recombinant PKR proteins were isolated from 
the ribosomal salt-wash fraction essentially as previously 
described (Samuel etaL, 1986). The 0.8 M ribosomal salt- 
wash fraction from transfected cells containing recombi- 
nant PKR protein was chromatographed on a DEAE-cellu- 
lose column, a step which removed endogenous nucleic 
acids and further purified the PKR from other proteins. 
Eluate fractions containing PKR were pooled, aliquoted, 
frozen in LN2, and stored at -80 ° . 
The relative concentrations of the partially purified re- 
combinant PKR protein preparations were determined 
by Western immunoblot analysis using both monoclonal 
antibody 71/10 (kindly provided by Dr. Ara Hovanessian, 
Paris) and-polyclonal PKR antisera (Thomis et al., 1992). 
The PKR Western signals were compared to a PKR stan- 
dard of known concentration, purified HIS-K296R(1-551) 
(Thomis and Samuel, 1993), in order to determine the 
molar concentration of the recombinant PKR proteins. 
Preparation of RNA 
The transcription vectors pT7VA~ and pT7TAR were 
used to prepare the adenovirus VA~(1-160) RNA and the 
HIV TAR(I-82) RNA as previously described (McCor- 
mack et aL, 1992). For gel mobility-shift analysis, the 
RNAs were purified by fractionation on 6 M urea-10% 
polyacrylamide gels. Heterogenous pl,pC RNA obtained 
from the Antiviral Substances Program, NIH, was size- 
fractionated by 7 M urea-polyacrylamide gel electropho- 
resis. 
Gel mobility-shift analysis 
Gel mobility-shift analyses were performed essentially 
as described (Gatignol et al., 1993) with the following 
modifications. The final reaction mixture (10 #1) contained 
approximately 1 ng of recombinant PKR protein and vary- 
ing concentrations of 32P-labeled VA~ RNA probe (sp act 
>1 x 107 cpm/pmol) in 15 mMTris-HCi, pH 7.8, 70 mM 
NaCI, 10 mM KCI, 1 mM EDTA, 6% glycerol (v/v), 0.01% 
Triton X-100 (v/v), 25 ng ovalbumin, 2 units rRNasin (Pro- 
mega), and 10 ng of Torula yeast RNA. Gel-shift reaction 
mixtures were incubated for 20 min at room temperature 
before loading onto a 10% native polyacryiamide gel (80~1 
acrylamide-bisacrylamide) in 0.5× Tris-borate EDTA 
buffer. The gel was prerun at 4 ° for >1 hr at 200 V; 40 
ml of a 2% glycerol solution was added to the wells prior 
to loading the samples. Electrophoresis was at 280 V for 
5 hr or until the xylene cyanol marker was approximately 
3 cm from the bottom of the gel. Gels were then dried 
and subjected to autoradiography. In gel-shift competi- 
tion experiments, the competitor RNA was added at the 
same time as the 32p-labeled VA~ RNA probe. 
Determination of dissociation constants (Ks) 
Gel-shift analysis was utilized to determine the disso- 
ciation constants of the PKR proteins K295R(1-551) and 
Wt(1-243) for adenovirus VA~ RNA. Dissociation con- 
stants were calculated by regression analysis of the rela- 
tive amount of PKR-RNA complex formed in the pres- 
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ence of varying amounts of 32P-labeled VA~ RNA (Reich 
eta/ . ,  1992). Following autoradiography, the VAI RNA 
probe and the PKR-VA~ complexes were excised from 
the dried gel using the autoradiogram as a template. 
The excisedgel slices were measured for 32p Cerenkov 
counts using a Beckman LS 1801 system. Binding data 
was analyzed by the KinetAsyst program (IntelliKinetics, 
State College, PA). 
The dissociation constants of K296R(1-561) and Wt(1 - 
243) proteins for VAI(1-160) RNA, TAR(1-82) RNA, and 
pl,pC RNA were also determined by competition analysis. 
This analysis was also performed with 3H-labeled VAp as 
the competitor to confirm the results obtained by the 
direct titration of 32P-labeled VAj RNA. The MINSQ soft- 
ware from Micromath Science Software was used to cal- 
culate the K/for both pl:pC RNA and TAR RNA, using 32p_ 
labeled VAj RNA as the probe. The quadratic equation 
describing the coupled equilibria, shown below for PKR- 
VAI (EC) and PKR-competitor (El), was recently de- 
scribed by Reich et al. (1992). 
Kc = [E][C]/[EC] 
K, = [E][fJ/[EI] 
[/] =/o  - [EJ] 
[El] = Eo - lEO] - [E] = Eo - lEO] - (Ko[EC]/[C]) 
[EC]2{Ko(1 + Ko/[C]} 
+ [EC]{Ko(/o - Eo + KI) + K/[C]} - K,[C]Eo = O. 
By using the quadratic equation to solve for EC we are 
able to use this model to fit the experimental data of EC 
versus /o, to obtain the value for Kr. 
-{Ko(Ao - Eo + K/> + K/[C]} + {(Ko(Ao - Eo + K/) 
+ K,[O]) 2 - 4(K~ + K2/[C])(-K,[C]Eo)} u2 
EC= 
2(K~ + K;/[C] 
RESULTS 
Gel-shift  analysis  of recombinant  PKR as a funct ion of 
VAI RNA probe concentrat ion 
To determine the Ko of the Wt(1-243) protein for the 
adenovirus VA~ RNA, gel mobility-shift assays were per- 
formed using varying concentrations of VAI RNA ligand 
and a constant concentration of PKR protein. The concen- 
tration of recombinant PKR protein was determined by 
quantitative Western analysis, using both a monoclonal 
PKR antibody (Fig. 1) and polyclonal PKR antiserum (data 
not shown) with purified HIS-K296R(1-551) protein as an 
internal standard. 
The Wt(1-243) protein bound VA~ RNA as two spe- 
cific complexes, designated complex I and complex II 
(Fig. 2A, lanes 2-12). The formation of complex I and 
II was dependent upon the concentration of the VA~ 
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FIG. 1. Determination of PKR concentration. Recombinant PKR pro- 
teins isolated from transfected COS cells and fractionated by DEAE- 
cellulose chromatography were separated by NaDodSQ~-PAGE and 
subjected to Western analysis using monoclonal antisera and the ECL 
Western blotting procedure (Amersham) as described under Materials 
and Methods. 
RNA in the gel mobility-shift reaction. Both complexes 
I and II were present when the RNA was limiting (Fig. 
2A, lanes 2-8), but when the VA~ RNA was in excess, 
only complex I was formed (Fig. 2A, lanes 9-12). Com- 
plexes I and II were formed in comparable amounts at 
a VAt RNA concentration of 7.7 x 10 -1° M;the  addition 
of PKR monoclonal antiserum supershifted both com- 
plex I and complex II (Fig. 2A, compare lanes 7 and 
14). When an endogenous COS cell protein preparation 
isolated from cells, not transfected with PKR, was ex- 
amined as a control, a minor protein species which 
bound VA~ RNA, designated RSW for ribosome salt 
wash, was detected (Fig. 2B). However, the endoge- 
nous RSW complex was not supershifted by the PKR 
monoclonal antibody (Fig. 2B, lane 14). Prior studies 
revealed that endogenous expression of monkey PKR 
in COS cells was extremely low relative to vector-en- 
coded PKR expression (Thomis and Samuel, 1992; 
McOormack et al., 1994). 
Gel-shift  analysis  of recombinant  K296R(1-551)  and 
K64E/K296R(1-551)  as a function of VA~ RNA probe 
concentrat ion 
RNA gel mobility-shift assays were performed using 
a constant concentration of K296R(1-551) and varying 
concentrations of VAj RNA (Fig. 3A). The K296R(1-551) 
PKR protein formed both complexes I and II when the VA~ 
RNA was limiting (Fig. 3A, lanes 2-6), but only complex I 
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FIG. 2. Gel mobility-shift analysis of PKR Wt(1-243) as a function of VA~ RNA probe concentration. (A) Recombinant PKR Wt(1-243). The Wt(1- 
243) protein concentration was kept constant at 7.0 x 10 -~° M, while the concentration of the S2P-labeled VA~ RNA ligand was varied from 1 x 
10 -~° to 5.8 X 10 -3 M. The I and II notation bordering the autoradiogram indicate the positions of the two complexes of shifted VA~ RNA which 
were super-shifted by PKR monoclonal antibody (A, compare lanes 7 and 14). (B) Control protein preparation isolated from COS cells transfected 
with the pJC119 vector without insert. RSW indicates the position of the complex formed by an endogenous RNA-binding protein which was not 
super-shifted in the presence of monoclonal antibody to PKR (B, lane 14). Lanes 1 and 13 contain 32P-labeied VAE RNA probe with no added protein 
at a concentration of 1 x 10 -~° and 7.7 x 10 10 M, respectively. Lanes 2-12 contain an increasing concentration of 32P-labeIad VA~ RNA with the 
indicated concentration in units of 1 × 10 -~° M above each respective lane. Lane 14, contains the same concentration of protein and VA~ probe 
as lane 7, except monoclonal antibody to PKR was added after the protein-RNA complex was formed (A and B). 
was  present  when the VA~ RNA was  in excess  (Fig, 3A, 
lanes  7 -9) ,  By cont rast ,  the RNA-b ind ing  act iv i ty  of  the 
K64E/K296R(1-551)  pro te in  was  poor  when compared  to 
the act iv i ty  of K296R(1-551)  (Figs. 3B and  3A, respec-  
t ively). 
Quant i ta t ion  o f  Wt (1 -243) ,  K296R(1-551) ,  and  K64E/  
K296R(1-551)  VA~ RNA-b ind ing  data  
The  PKR d issoc ia t ion  constant  of Wt (1 -243)  and 
K296R(1-551)  fo r  VA~ RNA was  determined  by regress ion  
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FIG. 3. Gel mobility-shift analysis of K296R(1-551) and K64E/K296R(1-551) as a function of VA~ RNA probe concentration. The recombinant PKR 
proteins K296R(1-551) and K64E/K296R(1-551) were analyzed for their ability to bind a2P-labeled VA~ RNA. The PKR protein concentration was held 
constant (lanes 2-9), while the concentration of VA~ RNA ligand was varied from 1.9 x 10 -~° to 3.23 × 10 -9 M. (A) The K296R(1 551) protein was 
analyzed at the concentration of 4.0 x 10 -~° M (lanes 2-9). (B) The K64E/K296R(1-551) protein analyzed at the concentration of 3.0 × 10 ~0 M. 
Lane 1 contains free VA~ probe at a concentration of 1.9 × 10 10 M with no added protein. Lanes 2 9 contain an increasing concentration of 32p_ 
labeled VA~ RNA with the indicated concentration in units of 1 × 10 -1° M above each respective lane. Lane 10 contains free probe at a concentration 
of 3.23 x 10 -9 M with no added protein. I and II, PKR specific complexes I and II; RSW, endogenous complex. 
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FIG. 4. Quantitation of PKR RNA-binding affinity to VA~ RNA. Binding 
of VA~ RNA to the Wt(1-243), K296R(1-551), and K64E/K296R(1-551) 
PKR proteins was performed as a function of VA~ RNA concentra- 
tion; quantitation was performed as described under Materials and 
Methods. 
analysis of the relative amount of complex formed at 
varying concentrations of 32P-labeled VA~ RNA (Fig. 4). 
The Ko for VA~ RNA calculated for the truncated Wt(1- 
243) PKR protein was 1.7 _+ 0.6 x 10 -9 M. The Ko for 
full-length K296R(1-551) protein was comparable, 1.2 _+ 
0.3 × 10 ~ M, as summarized in Table 1. The full-length 
R~ motif mutant, K64E/K296R(1-551 ), bound VAE RNA very 
poorly (Fig. 4). 
RNA gel-shift competition analysis of Wt(1-243) and 
K296R(1-551) using phpC RNA competitor with VA~ 
RNA probe 
The dissociation constants of PKR for VAr RNA and 
pl:pC RNA were analyzed using a mobility-shift competi- 
tion assay. The concentrations of both PKR protein and 
VA~ RNA probe were held constant, and the concentration 
of a 200-bp pl:pC RNA competitor was varied (Fig. 5). 
The pl:pC effectively competed the binding of 32p-labeled 
VA~ RNA, both to the truncated Wt(1-243) PKR protein 
(Fig. 5A) and the full-length K296R(1-551) PKR protein 
(Fig. 5B). The KD of Wt(1 -243) for pl:pC RNA, measured 
by competition analysis, was 2.4 + 0.1 X 10 -9 M; the Ko 
of K296R(1-551) for pl:pC RNA was 1.7 _+ 1.0 x 10 -9 M 
(Table 2). 
RNA gel-shift competition analysis of Wt(1-243) using 
both VA~ and TAR RNA competitor with VA~ RNA 
probe 
tion analysis was 3.6 _+ 0.2 X 10 9 M (Table 2). The 
KD of Wt(1-243) and K296R(1-551) for TAR RNA were 
1.6 _+ 0.1 x 10 -7 and 1.9 _+ 0.2 x 10 _7 M, respectively 
(Table 2). 
DISCUSSION 
Three important points emerge from the results re- 
ported herein. The truncated Wt(1-243) and the full- 
length K296R(1-551) PKR proteins bound adenovirus VA~ 
RNA With comparable efficiency as measured by a gel 
mobility-shift assay. However, the adenovirus VA~ RNA 
was bound with approximately 100-fold greater affinity 
than was HIV TAR RNA by both Wt(1-243) and K296R(1- 
551) PKR proteins. Finally, the full-length K64E/K296R(1- 
551) PKR protein with an altered R~ motif displayed a 
much lower relative binding activity for VA~ RNA than did 
the full-length K296R(1-551) protein. 
The quantitative nature of the results obtained by gel 
mobility-shift analysis of native PKR proteins extends our 
understanding of the RNA-binding activity of these forms 
of PKR deduced from Northwestern gel-blot analysis 
(McOormack et eL, 1994). The Wt(1-243) and K296R(1 - 
551) proteins bound VAt RNA with comparable affinity, 
both proteins displaying a Ks of approximately 1.4 x 10 -9 
M (Table 1). These results conclusively demonstrate that 
the necessary residues for efficient RNA-binding activity 
are contained within the N-terminal 243 amino acids of 
PKR. Likewise, the results suggest that the residues 
within the catalytic C-terminus of PKR do not significantly 
affect the RNA-binding properties attributed to the N- 
terminus of the protein. 
Activation and/or inhibition of PKR autophosphoryla- 
tion occurs upon RNA-binding (Katze, 1992; Mathews, 
1993; Samuel, 1991). It is not definitively known whether 
the regulatory N-terminus of PKR acts as a steric or allo- 
steric inhibitor of the catalytic C-terminus, but this ap- 
pears to be a likely possibility. For example, the observa- 
tion that ATP can be cross-linked to the PKR kinase only 
in the presence of dsRNA (Bischoff and Samuel, 1985; 
Galabru and Hovanessian, 1987) implies that the PKR 
protein undergoes a RNA-dependent conformational 
change which enables it to bind ATP. It also has been 
proposed that the VA~ RNA functions as an inhibitor of 
PKR activation by eliciting a specific conformational 
The relative ability of adenovirus VA~ RNA and HIV TAR 
RNA, added as 3H-labeled RNAs, to compete with the 
binding of 32P-labeled VA~ RNA probe to PKR was exam- 
ined. The binding of 32p-labeled VA~ RNA to the Wt(1- 
243) (Fig. 6) and the K296R(1-551) (data not shown) re- 
combinant proteins was much more effectively competed 
by VA~ RNA than by TAR RNA. The Ko of Wt(1-243) for 
VAI RNA by competition analysis was 1.6 _+ 0.5 x 10 -9 
M; the KD of K296R(1-551) for VA~ RNA by competi- 
TABLE 1 
DISSOCIATION CONSTANTS DETERMINED BY VAi RNA TITRATION ANALYSIS a 
PKR protein RNA Ko 
Wt(1 243) VA~ 1.7_+ 0.6 x 10 9M 
K296R (1-551) VA~ 1.2 _+ 0.3 :x: 10 g M 
a Constants derived from independent experiments similar to those 
shown in Figs. 2-4 as described under Materials and Methods. 
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FIG. 5. Gel-shift competition analysis of PKR with VA~ RNA as the probe and phpC RNA as the competitor. The concentrations ofthe recombinant 
PKR proteins and the 9~P-labeled VA~ RNA probe (2.3 x 10 _9 M) were kept constant, and the amount of the pl=pC RNA competitor was varied. (A) 
Wt(1-243) protein at 5.8 X 10 -~° M. (B) K296R(1-551) protein at 2.4 X 10 -l° M. Lane 1, contains free probe; lane 2, no competitor added; lane 3, 
contains 3.6 x 10 ~o M phpC RNA competitor; lane 4, contains 7.2 X 10 -~° M pkpC; lane 5, 1.4 X 10 ~ M phpC; lane 6, 2.8 x 10 -9 M pl=pC; lane 
7, 5.8 X 10 -~ M phpC; lane 8, 1.15 x 10 8M pl=pC; and lane 9, 2.3 >4 10 -3 M phpC RNA competitor. 
change in the PKR protein, which thereby prevents auto- 
phosphorylation (Green and Mathews, 1992). 
The RNA-binding activity displayed by K64E/K296R(1 - 
551) PKR was substantially lower than that of K296R(1- 
551) PKR. We were unable to saturate the binding of VA~ 
RNA to the K64E/K296R(1-551) double-mutant protein. It 
is not yet known if the K64E mutation significantly desta- 
bilizes the overall folding of PKR or alters the localized 
structure of the recombinant PKR protein, thereby re- 
sulting in impaired RNA-binding activity as measured 
both by gel mobility-shift analysis with native protein as 
described herein and by Northwestern analysis with re- 
natured protein (McCormack et al., 1994). 
PKR appears to bind two distinct regions of VA~ RNA, 
the double-stranded regions of the apical stem (Mellits 
et al., 1990) and the central core of VA~ RNA which has 
been implicated in the function of kinase inhibition (Fur- 
tado et al., 1989; Ghadge et aL, 1991). The PKR protein 
contains two copies (R~ and R,) of the RNA-binding R 
motif. R~ and Ru seem to function as nonequivalent units; 
both copies are required for maximal RNA-binding activ- 
ity (Green and Mathews, 1992; McCormack et aL, 1992, 
1994). The motif R~ is functional alone when expressed 
as a TrpE fusion protein, whereas the motif RH is not 
(McCormack et al., 1992). Mutations in either motif R~ or 
motif R, greatly reduce the RNA-binding activity of PKR 
(Green and Mathews, 1992; McOormack et aL, 1994). It 
is conceivable that the o~-helical motifs R~ and RH each 
bind directlyto distinct regions ofVA~ RNA and phpC RNA 
(Green and Mathews, 1992). However, the dissociation 
constants of Wt(1-243) and K296R(1-551) for phpC RNA 
and VA~ RNA differed by less than twofold. This finding is 
consistent with the conclusion that the double-stranded 
regions ofVAk RNA are indeed necessary for PKR binding 
(Mellits et aL, 1990). These results are also consistent 
with the notion that there is a single dsRNA binding site 
on PKR which is capable of binding both activator and 
inhibitor RNAs (McCormack eta/., 1992, 1994; Green and 
Mathews, 1992; Manche et aL, 1992). 
Curiously, both the Wt(1-243) and K296R(1-551) pro- 
teins each compiexed with VA~ RNA to yield two unique 
complexes, designated land II, detected by the gel-shift 
assay (Figs. 2A, 4A and 4B). This observation suggests 
dimerization of PKR may occur, mediated by the N-termi- 
nal region of the protein. The formation of complex II 
occurred only when the VA~ RNA was limiting, either at 
TABLE 2 
DISSOCIATION CONSTANTS DETERMINED BY RNA COMPETmON ANALYSIS a 
PKR protein RNA Ko 
Wt (1-243) VA~ 1.6 _+ 0.5 X 10-9M 
K296R (1-551) VAI 3.6 +_ 0.2 X 10-9M 
Wt (1-243) TAR 1.6 _+ 0.1 X 10-7M 
K296R (1-551) TAR 1.9 _+ 0.2 X 10-7M 
Wt (1-243) phpC 2.4 4- 0.1 X 10-9M 
K296R (1-551) phpC 1.7 _+ 1.0 X 10-9M 
a Constants derived from independent experiments similar to those 
shown in Figs. 5 and 6 as described under Materials nd Methods. 
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Wt(1-243) 
competitor VA[ RNA TAR RNA 
I ] r oo l  
l x l0"°M ~o ~ ~ ~ ~ o ~o o 
I ! 
1 2 3 4 5 6 7 8 9 10 11 12 13 
FIG, 6. Gel-shift competition analysis of PKR with VAf RNA as the 
probe and either VA~ R NA or TAR RNA as the competitor. The concentra- 
tion of PKR Wt(1-243) protein (7.0 X 10 -~° M) and 32P-labeled VAj RNA 
probe (2.7 X 10 -9 M) were kept constant, and the concentration of 3H- 
labeled RNA competitor was varied. Lane 1 contains free VAr RNA 
probe. Lanes 2 and 8 contain PKR protein and VAt RNA probe, with no 
TAR RNA competitor added. Lanes 3 to 7 contain increasing amounts 
of 3H-labeled VA~ RNA competitor, and lanes 9 to 13 contain increasing 
amounts of 3H-labeled TAR RNA competitor. 
high concentration of PKR protein (unpublished observa- 
tions) or at low concentration of VAt RNA probe (Figs. 
2A, 4A and 4B). The VA~ RNA was shifted to a single 
complex under low concentrations of PKR protein [either 
K296R(1-551) or Wt(1-243)], and complex II was specifi- 
cally formed when the VAj RNA probe was limiting. Both 
the bound I and II complexes are PKR specific, because 
they were both supershifted by monoclonal antibody to 
the PKR protein (Fig. 2A). By contrast, the endogenous 
RSW complex was not supershifted by the monoclonal 
antibody (Fig. 2B). 
Manche eta/. (1992) also observed multiple PKR-RNA 
complexes when examining dsRNA and partially purified 
PKR in a gel-shift assay; furthermore, the number of com- 
plexes increased with larger dsRNA probes. They pro- 
posed that the multiple-shifted complexes resulted from 
multiple PKR molecules binding to the same RNA mole- 
cule. Interestingly, we also detected both complex I and 
II when TAR RNA was used as the probe in the gel 
mobility-shift analysis instead of VAt RNA (unpublished 
results). Possibly the complex I represents monomeric 
PKR, whereas the complex II represents either a homodi- 
mer or a heterodimer of PKR. It is unlikely that the com- 
plex II represents nonspecific protein-protein oligomer- 
ization, because the complex was formed over a wide 
range of protein concentrations and was highly depen- 
dent on the concentration of the VA~ RNA. Furthermore, 
nonspecific PKR RNA-binding would presumably be 
characterized by a much lower affinity than the specific 
binding of PKR to VA~ RNA. 
The dissociation constants for complexes I and II were 
comparable. However, when the stoichiometry of PKR 
protein to VAj RNA was 1=1, complex ] was the predomi- 
nant form (Figs. 2A and 4A). When the VA~ concentration 
was increased, complex II disappeared while complex I 
increased in amount (Figs 2A and 3A). These results 
are consistent with PKR dimerization, which has been 
reported by Langland and Jacobs (1992). However, we
cannot exclude the alternative possibility that the differ- 
ences between complexes I and II arise from an alter- 
ation in PKR conformation, or post-translational modifica- 
tion of PKR, or by the association of PKR with other ef- 
lector proteins. For example, the DNA-binding activity of 
the Fos and Jun proteins is altered by post-translational 
modification, by the nature of their dimerization, and by 
their association with specific effector proteins (Alle- 
gretto et aL, 1990). 
Attempts were made to estimate the off-rate of the 
ligand VA~ RNA, both with full-length PKR protein 
K296R(1-551) and the N-terminal RNA-binding domain 
Wt(1-243), using the gel-shift assay. When 32P-labeled 
VA~ RNA-protein complexes were preformed before the 
addition of excess 3H-labeled VA~ RNA, all of the 32p_ 
labeled VA~ RNA was displaced by the 3H-labeled VA~ 
RNA within 1 min. However, an on-rate minimum of 5 x 
106 mol/sec can be estimated for both the recombinant 
Wt(1-243) and K296R(1-551) proteins assuming that six 
half-lives had passed. 
The explanation for the lower affinity of PKR for TAR 
RNA as compared to VA RNA is unclear. Perhaps the 
82-nt single-stranded TAR RNA was either of insufficient 
size or present in incorrect context to form the optimal 
higher-ordered structure quired for stable interaction 
with PKR. The size of dsRNA required to bind efficiently 
to PKR is estimated at approximately 85 bp, while du- 
plexes of 40 bp bind only weakly (Manche et aL, 1992). 
interestingly, the cellular TAR RNA-binding protein which 
contains the R motif binds TAR RNA with an affinity simi- 
lar (Gatignol etaL, 1993) to that observed herein for PKR. 
Although shifted complexes I and II both contained PKR 
because they were both supershifted upon addition of 
PKR-specific monoclonal antibody, we cannot exclude 
the-possibility that a second protein was also present in 
the complex in addition to PKR. The second protein might 
differentially affect the affinity of PKR for TAR and VA~ 
RNAs. 
In conclusion, we have shown that full-length 
[K296R(1-551)] and truncated [Wt(1-243)] PKR proteins 
were able to bind both VAp RNA and pl=pC RNA with 
comparable affinity, characterized by a KD of approxi- 
mately 2.0 X 10 -9 M for both forms of PKR and both 
RNAs. By contrast, the binding of TAR RNA differed by 
about 100-fold, displaying a K~ of approximately 2.0 x 
10 -7 M with both forms of PKR. These results demon- 
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strate unequivocally that the different viral RNAs which 
affect PKR enzymic function may not necessarily interact 
with PKR in a quantitatively identical manner. Our under- 
standing of the mechanism of PKR activation and inhibi- 
tion will be facilitated, by the identification of additional 
RNAs, including possibly cellular RNAs that modulate 
PKR activity, and by determination of the three-dimen- 
sional structure of PKR complexed with activator and 
inhibitor RNAs. 
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